---
title: 'N-of-1 trials in epilepsy: A systematic review and lessons paving the way
  forward'
date: '2024-09-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39254637/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240910182418&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'OBJECTIVE: Defined as prospective single-patient crossover studies with
  repeated paired cycles of active and control intervention, N-of-1 trials have gained
  attention as an option to obtain high-quality evidence of efficacy, particularly
  for patients with rare epilepsies in whom conduction of well-powered randomized
  controlled trials can be challenging. The objective of this systematic review is
  to provide an appraisal of the literature on N-of-1 trials in individuals with ...'
disable_comments: true
---
OBJECTIVE: Defined as prospective single-patient crossover studies with repeated paired cycles of active and control intervention, N-of-1 trials have gained attention as an option to obtain high-quality evidence of efficacy, particularly for patients with rare epilepsies in whom conduction of well-powered randomized controlled trials can be challenging. The objective of this systematic review is to provide an appraisal of the literature on N-of-1 trials in individuals with ...